
PfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety review
Safety Monitoring Committee clears clinical trial to advance to younger age groups Physician-scientists at Groupe de Recherche Action en Santé (GRAS) in Burkina Faso have successfully completed initial safety evaluations in 30 adult Burkinabés as the first …